|
|
 |
 |
 |
Leading Pharmas Face
Years of Patent Expirations
Following the expected large number of patent
expirations that will take place by 2010, a second
set of drugs will come off patent between 2010 and
2014. Eli Lilly and Pfizer will be hardest hit by
this second wave of expirations. Five of Lilly's
drugs representing about 60 percent of the company's
pharma revenues will be affected. Pfizer could lose
as much as $18 billion (Euro 12.2 billion) as its
key drugs Lipitor, Viagra and Celebrex, among
others, lose their patent protection. Pfizer has
also struggled with the development of new drugs,
having pulled its anti-diabetes therapy Exubera from
the market. IMS Health predicts that the growth of
the pharma industry will decline in 2008 to 5 to 6
percent from the 2007 level of 6 to 7 percent.
Generics, on the other hand, will see strong growth
by 14 to 15 percent in 2007 alone.
While Pfizer does not have a strong pipeline to
counteract its losses due to patent expirations, it
is looking to cut costs by moving R&D efforts to
Asia and increasing outsourcing in the region. The
company may outsource as much as 30 percent of its
manufacturing in Asia, up from the current level of
15 percent. Pfizer will close several research sites
and two manufacturing facilities in Brooklyn, NY and
Omaha, NE, plus sell a third production site in
Feucht, Germany.
AstraZeneca also announced that is will begin
shifting operations to Asia and accelerate
activities in the Japanese market. |
 |
 |
 |
|
 |
|
|
 |
 |
 |
Dow Makes
Cuts
To
achieve annual savings of about $180
million, Dow Chemical will close plants and
eliminate as many as 1,000 jobs. Facilities
likely to be shut down include an
agrochemicals intermediates plant in
Lautebourg, France, Hydroxymethyl cellulose
plant in Aratu, Brazil, a Styrene plant in
Camaçari, Brazil and a Union Carbide
Polypropylene plant in St Charles,
Louisiana. R&D activities at a Union Carbide
site in South Charleston, W.Va. will also be
reduced significantly. In addition, the
company will exit the automotive sealants
business in North America, Asia Pacific and
Latin America. Further decisions could be
pending with other commodities businesses.
These actions will make capital available
for investment in projects in Asia and the
Middle East. Dow Chemical recently announced
that it will invest in an $11 billion joint
venture with Petrochemical Industries Co. in
order to gain access to cheaper feedstocks.
Dow will sell to PIC for $9.5 billion a 50
percent share in five of its global
businesses that are worth about $19 billion.
The JV will be headquartered in the United
States, will operate as a separate company
(its name has not been chosen yet) and will
produce Polyethylene, Ethylenamines,
Ethanolamines, Polypropylene and
Polycarbonate. The two companies already
have other joint ventures and have been
working together for 10 years. The new joint
enterprise will mean that Dow will have
projects integrated from feedstocks to
derivatives. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
PPG has
Trouble with Sale of Auto Glass Business
PPG's
$500 million sale of its automotive glass
businesses to investment firm Platinum
Equity has run into trouble. Platinum has
accused PPG of inflating the value of its
businesses and filed a lawsuit seeking to
abandon the deal and alleging that PPG
provided false revenue projections,
understated pension liabilities and
obligations and deferred several million
dollars of maintenance expenditures.
Platinum says that if it had known this
information it would have lowered its
purchase price or not entered into a
purchase agreement. The company is seeking
from PPG the costs and expenses incurred in
connection with the transaction, lost
opportunity costs and punitive damages.
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Reorganization at BASF

Effective Jan. 1, 2008, BASF will operate
with six business segments rather than five.
The segments include chemicals, plastics,
functional solutions, performance products,
agricultural solutions, and oil and gas. The
new functional solutions unit will
incorporate the catalysts, construction
chemicals and coatings divisions and will
largely serve the automotive and
construction industries. Performance
products will include the newly created care
chemicals division (fine chemicals plus
detergents and cleaners) plus acrylics and
dispersions, which previously was the
functional polymers business. The
performance chemicals segment will target
the oil and refinery, coatings and plastics
and leather and textile industries. BASF
will divest its styrenics business.
According to the company, the change will
enable BASF to be faster to market, closer
to customers, increase efficiency and ensure
greater cyclical resilience. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
China Gets
Tougher on Exports
After
cutting export tax rebates for over 2,000
products in 2007, China may apply further
pressure in 2008 on the export of light
industrial products such as plastics and
electrical appliances. The 2007 cuts,
however, do not appear to have affected the
level of exports, which grew by 20 percent
in November as compared to the same month in
2006. In general producers passed on price
increases that were accepted by buyers who
could not find alternative sources for these
materials.
The Chinese government might introduce taxes
on energy-intensive and environmentally
unfriendly products in addition to
maintaining the rebate cuts to further
reduce exports. The central government will
also release regulations on emissions and
safety performance for manufacturers
involved in the Chlor-alkali production
chain, which should create barriers to entry
into this industry. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Firms Fined
by South Korea for Polyethylene Price Fixing
Hanwha
Chemical, LG Chem, SK Energy, Samsung
General Chemicals, Seetec and Samsung Total
Petrochemicals received fines totaling $58.1
million (W 54.1 million) by South Korea's
Fair Trade Commission for fixing prices of
low density Polyethylene (LDPE) and linear
LDPE (LLDPE). The case is the second in
2007. The government previously fined
companies a total of $112.7 million (W 105
million) for forming domestic high density
PE (HDPE) and polypropylene (PP) cartels for
the past 12 years. The agency may expand its
investing to Styrene monomer as well.
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
New Price
Fixing Fines for European Companies
Denka,
DuPont, Dow Chemical, ENI and Tosoh have
been fined a total of $357 million (Europe
243.2 million) by the European Commission
(EC) for conspiring to fix prices of
Chloroprene rubber from at least 1993 to
2002. Bayer's Euro 201 million fine was
rescinded because the company was the first
to come forward with information.
In a separate case, the EC increased BASF's
fine for its part in a Choline chloride
cartel by $79,294 (Euro 54,000). BASF, Akzo
Nobel and UCB were initially fined a total
of Euro 66 million in 2004 for price-fixing
activities from June 1992 to April 1994.
BASF and UCB appealed the decision. In
response to the appeal, the court raised
BASF's fine but lowered UCB's amount by 90
percent, since UCB reported the European
activities of the cartel. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Potential
for Growth Abroad but Tough Times at Home
for U.S. Chemical Companies in 2008
Restrictions
on natural gas and rising crude oil prices
will have a negative impact on the United
States chemical industry in 2008. The energy
bill passed by Congress in late 2007
strongly pushes for increased biofuels and
will create a level of demand for natural
gas greater than current supplies.
Additionally, climate change legislation
that is expected to be adopted in 2008 will
likely force many chemical producers and
utilities to switch from coal to natural
gas, further heightening demand.
American chemical companies will be facing
this energy and raw material crisis at a
time when the country may be facing a
recession. The continuing decline in the
housing market will affect many segments of
the chemical industry. Automobile
production, while not expected to drop
further, is predicted to remain at the low
levels seen in 2008. Manufacturing sectors
not connected to housing or automobiles are
the only areas of the U.S. economy that are
expected to perform well in 2008.
Given the situation at home, many commodity
chemical producers in the United States are
looking to exports to maintain
profitability. The weak dollar is making
their products much more competitive in the
global chemical marketplace. Growing demand
overseas is also a favorable factor, as is
access to competitively priced feedstocks.
Outsourcing of pharmaceutical production
will continue, however. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
New Deals in
Contract Manufacturing
Several transactions have taken place
recently in the world of contract
manufacturing. Cambridge Major Laboratories
acquired Chemshop, a supplier of active
pharmaceutical ingredients (API) development
services. Cambridge will expand reactor
capacity and increase the laboratory
capabilities at the European site, which has
been renamed Cambridge Major Laboratories
Europe. PPG Industries completed the $65
million sale of its fine chemicals business
to ZaCh Systems, a subsidiary of Zambon
Company. PPG sold the business as part of
its strategy to focus on coatings and
specialty products.
Aptuit purchased the chemical development
business of Evotek for about $64.57 million
(Euro 44.36 million) to expand its
development services. Evotek sold the
business in order to focus on its high-end
research capabilities. Isochem sold its
NeoMPS peptides business to PolyPeptide
Laboratories Group for an undisclosed
amount. Finally, ownership of Vertellus
Specialties changed from Arsenal Capital
Partners to Wind Point Partners. Arsenal
formed Vertellus in 2006 by combining the
operations of Reilly Industries and
Rutherford Chemicals. Richard Preziotti, a
former executive at Honeywell, will take the
position of CEO at Vertellus. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
Big Pharma
Reductions Will Pay Off
More than 30,000 job cuts have been
announced by big pharma companies in 2007.
Analysts predict that these actions, while
painful, will benefit these key players in
the future. Novartis recently joined Eli
Lilly, Pfizer, GlaxoSmithKline,
Bristol-Myers Squibb and several others with
announcements of significant reductions in
personnel and plans for reorganizing
operations. In the end, according to
analysts, leaner businesses that have
shifted some operations overseas will be
better suited to compete with low-cost
producers in emerging markets. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Spotlight on
Biopharma
Major pharma companies are investing heavily
in biopharma firms as they look to biotech
for strong profits. Novartis AG has signed a
$1 billion R&D contract with MorphoSys AG
for the development of antibody-based
therapies. Merck & Co. agreed to pay $170
million to Addex Pharmaceuticals to develop
a treatment for Parkinson's disease and
Sanofi-Aventis will invest as much as $810
million in Regeneron Pharmaceuticals for
antibody-based research.
Many leading drugs on the market today are
biologics, such as Herceptin (Roche
Holding), Remicade (Johnson & Johnson) and
Humira (Abbot Labs). Sales of
biopharmaceuticals in the United States grew
20 percent in 2006 to reach $40.3 billion,
according to IMS Health. Biologics are also
attractive because they do not face generic
competition, at least in the United States,
where the FDA has yet to establish a
regulatory protocol.
At the same time, many biopharma firms are
anticipating decisions from the FDA that
will determine their future. Approval
decisions are expected in December 2007 for
drugs from Neurocrine BioSciences, BioMarin
and Pharmacyclics, while Biogen Idec,
Cardiome, Discovery Labs, Elan, Genentech,
Indevus Pharmaceuticals and Johnson &
Johnson will be waiting for decisions in
2008. Other companies that have yet to
formally submit drugs for approval but are
expected to do so include Advanced Life
Sciences, Genitope, ImClone Systems and
Medarex. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
Deal Between
Nufarm and ChemChina Cancelled
A
consortium of buyers led by ChemChina was
unable to formalize a proposal for the $2.63
billion takeover of Nufarm before the
deadline for expiration of the agreement. As
a result, talks between the two companies
have been halted. ChemChina, Blackstone and
Fox Paine Management had signed an
exclusivity agreement to buy Nufarm, but
Nufarm is no longer obligated to the group
now that the deed has expired. Nufarm
indicated that it is interested in speaking
with other potential bidders.
Separately, ChemChina also failed to come to
an agreement with the parent company of
Shandong Haihua about cooperation between
the two companies. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Fertilizer
Industry Facing Shortages of Key Materials
Phosphoric acid, a key raw material in the
production of phosphate fertilizers, will be
in tight supply through 2010, according to
the International Fertilizer Industry
Association. Additional capacity is being
added, but it will not be on-stream until
2011. Much of the material will be used for
domestic downstream applications in China
and Saudi Arabia, though, and most of the
capacity targeted for export is already
under contract. Urea supplies are also
tightening, as new production plants around
the world are experiencing delays. Industry
operating rates are currently at 90 percent.
Even if planned projects do come on-stream
on time, there will not be a surplus until
2010. Most urea is used as fertilizer, but
non-fertilizer applications are expected to
grow rapidly over the next few years, adding
to the need for increased capacity.
Prices for many fertilizers hit record highs
in 2007 as a result of an increased demand
for food at a time of low grain stocks.
Increased demand for crops used for biofuels
production and resulting high crop prices
also contributed to the rise in fertilizer
prices. These conditions continue to be
factors in 2008.
The shortness in the Phosphoric acid market
is impacting the Indian farm sector.
Domestic phosphate fertilizer producers are
not able to import the necessary quantities
of Phosphoric acid, resulting in idle
capacity. Prices for 2008 contracts are
significantly higher than 2007 levels and
are expected to climb further. India is also
the world's largest importer of Diammonium
phosphate (DAP) and Urea. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
China Market
Cooling Off?
Key
industry players in China predict that
demand for petrochemicals in China will slow
down in 2008 as government controls and high
energy and raw material costs take their
toll. The Chinese government has implemented
both financial controls and safety
regulations that are affecting the industry
at a time when crude oil costs are rising
rapidly. Further actions may include
additional tightening of credit and removal
of remaining export subsidies. Controls in
downstream markets such as the construction
industry are also having an impact.
Contraction in demand for Ethylene and
derivatives, as well as many of the major
polymer markets, is expected. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Middle East
Center of Chemical Activity
Ready
access to low-cost feedstocks is enabling
the Middle East to establish itself rapidly
as a major exporter of petrochemicals. The
level of building is placing significant
pressure on engineering firms and resources,
including skilled labor, materials and
construction equipment, resulting in the
delay of several projects. Rising feedstock
costs and constraints on some raw materials
(Ethane in particular) are also becoming
growing concerns.
Despite these difficulties, analysts predict
that producers in the Middle East will
become true global players, reaching
customers around the world and offering more
than Ethane-based derivatives. Successful
companies will be from global partnerships.
The diversity of projects (commodity and
specialty chemicals) and careful control of
costs will also be critical for companies
looking to take a top position in the
worldwide chemicals marketplace.
Companies building facilities include Kuwait
Olefins Co. (TKOC), a joint venture project
between Petrochemical Industries Co. of
Kuwait and Dow Chemical; Ras Tanura, a Dow
Chemical and Saudi Aramco project; Jam
Petrochemical Co. (JPC); Rabigh Refining &
Petrochemical project, a joint venture
between state-owned Saudi Aramco and
Sumitomo Chemical; Eastern Petrochemical (Sharq);
and Borouge, a joint venture between
Borealis and ADNOC.
Most of the projects are expected to be
on-stream by 2012. Many wonder about the
impact this increase in capacity will have
on the marketplace, as it will occur at the
same time that many new Asian plants will be
starting operations. Oversupply in Ethylene
is of particular concern. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Questionable
2008 for Olefins
High feedstock costs are likely to plaque
olefins producers around the world in 2008.
High crude oil prices are squeezing margins
for producer in the United States, Europe
and Asia. Some producers in Asia are
considering reducing exports to save costs,
which could reduce spot availability.
Supplies will be further tightened in the
region, with a significant number of
maintenance turnarounds scheduled in Japan
in 2008. Growing demand could place further
strain on the market. Traders are hopeful
that large production capacity in the Middle
East will provide access to material.
European producers are concerned about the
access that Asian and Middle Eastern
producers have to lower cost Ethylene. They
also must hope that downstream polymer
markets will accept the record high olefins
prices necessary for maintaining even slim
margins. In the United States, olefin
producers also face tight suppliers and high
crude oil costs. Strong demand for
derivatives and increased imports will
continue in 2008. There are also a number of
planned shutdowns scheduled in the Unites
States in 2008. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Russian
Petrochemical Industry Growing
The
Russian government has plans to develop its
petrochemical sector in order to take
advantage of its strong position in oil and
natural gas. Currently the country imports
over 50 percent of the plastics and
commodity chemicals it needs. Plans include
raising overall production by 40 percent
between 2007 and 2015 through investment of
about $163 billion (Euro 11 billion, Rs 4
trillion). Dow Chemical and BASF are two
western companies already establishing plans
to advantage of this growth opportunity.
Ethylene, Polypropylene, Polyethylene and
Polyvinyl chloride facilities are being
planned or are nearing the construction
stage. Other oil companies have announced
plans to build petrochemical hubs. The
Russian government has also indicated that
it may revise the country's environmental,
health and safety regulations so they are in
line with international regulations such as
Reach in the EU. Most analysts expect that
both the new facilities and any new
regulations will be slow in materializing,
but will occur eventually. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
Production
Outages Affect TDI Supply
Production outages in Asia, Latin America
and Europe have led to a tightness in the
global supply of Toluene diisocyanate (TDI)
for several months. The United States has
been a key supplier until recently, when
production issues affected the ability of
producers in the country to meet demand. Dow
Chemical closed its plant for routine
maintenance and then extended the shutdown
to complete additional work. ABASF plant was
also operating at reduced rates due to a
supply shortage of a key raw material.
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
Akzo Gets OK
from EU for ICI Purchase with Conditions
Akzo
Nobel has agreed to divest several
decorative coatings businesses in the UK,
Ireland, Belgium and Canada to meet
requirements set by the European Commission
and Canadian Competition Bureau for approval
of its $16 billion (Europe 11 billion)
acquisition of ICI. The transaction is
expected to be completed on Jan. 2, 2008. In
advance of the closure, Akzo is reorganizing
the company into three business units -
Decorative Paints, Performance Coatings an
Specialty Chemicals. The ICI businesses will
be merged appropriately, with its specialty
polymer operations becoming part of the
specialty chemicals business and its
packaging coatings activities being placed
in the performance coatings unit.
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
Formation of
LyondellBasell Industries Complete

The $19.4 billion (Euro 13.6 billion)
acquisition of Lyondell Chemical by Basell
is complete. LyondellBasell Industries has
annual revenues of about $43 billion, making
it the third-largest independent chemical
company in the world. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Next Big Car
Color: Green
Specialty chemicals are making it possible
for the next generation of cars to be much
greener than before. Biomaterials, plastics,
and greener tires will be incorporated into
vehicles that can be run efficiently on
alternative fuels. Plastic in particular is
making cars lighter. Each pound of plastic
used in a car replaces 2 to 3 pounds of
heavier materials, providing improved fuel
economy. The use of plastics in cars
produced in the United States has increased
by 18 percent since 2000 and 75 percent
since 1990, according to the American
Chemistry Council. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
A. Schulman
Appoints New CEO
Goodyear Tire & Rubber's chief technical
officer Joseph Gingo has been selected as
the new president and CEO of plastics and
resins maker A. Schulman, replacing Terry
Haines, effective Jan. 1, 2008. Schulman had
said previously that it was considering
strategic alternatives for the company,
including its sale or merger. Schulman has
urged shareholders to reject candidates for
the company's board chosen by investment
fund Ramius Capital, which owns 7.4 percent
of Schulman. Ramius does not approve of the
choice of Gingo for the CEO position,
preferring to bring in someone from outside
the company in order to fully consider all
strategic options. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Cabot Gets
New Leader
Patrick
M. Prevost, currently president of the
performance chemicals business of BASF will
become the new president and CEO of Cabot
Corporation, succeeding Kennett F. Burnes,
who retired on Jan. 1, 2008. John F.
O'Brien, a member of Cabot's board of
directors, is expected to be named as
chairman when Burnes retires from that
position in March 2008. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Change of
Leadership at Eli Lilly
Eli Lilly and Company CEO Sidney Taurel will
retire at the end of March 2008 and be
succeeded by the current COO, John C.
Lechleiter. Taurel will also leave the
position of chairman of the board at the end
of the year. Lechleiter joined the company
in 1979 as an organic chemist. His
scientific background is unusual for pharma
company heads and could be an advantage for
Lilly, according to analysts. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Novartis
Announces Major Job Cuts
Novartis plans to achieve cost savings of
$1.6 billion (Euro 1.1 billion) by 2010
through its "Forward" plan, which includes
elimination of 2,500 jobs (2.5 percent of
its workforce) worldwide. The announcement
follows the delay or withdrawal of several
potential new products for the company. The
cuts will be in management, R&D and sales,
with a goal of simplifying the organization.
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
Biofuel and
Other Alternative Energy Sources Set for
Growth
Transportation fuels will be the fastest
growing energy sector in 2030, according to
ExxonMobil. Alterative fuels, particularly
biodiesel and bioethanol, will increase from
just 1 percent of the global market to
between 5 and 10 percent by 2017. Government
mandates and the need to replace dwindling
petrochemical reserves will be major drivers
of this growth. Advances in cellullosic
technology will be critical for the
significant increase of biofuel consumption,
though, as the amount of corn and vegetable
oil-based raw materials are limited.
Biobutanol is a next generation biofuel that
could become commercially available in a few
years. Hydrogen fueling stations could be
constructed in California by 2015.
Gas-to-liquids (GTL) and coal-to-liquids (CTL)
will also be used to produce cleaner-burning
synthetic fuels |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
More
Transportation Strikes for European Chems
Further
strikes by rail and road shippers have
affected chemical producers in Europe.
French rail workers announced the second
strike in less than a month to protest
proposed reforms to pension plans. In Italy,
truck drivers went on strike to protest high
fuel prices, disrupting chemical shipments
and causing some plants to shut down due to
a shortage in the raw materials supply. The
strike was resolved after three days.
German rail workers promised to go on strike
again on Jan. 7, 2008, after negotiations
with rail operator Deutsche Bahn failed, but
resumed discussions shortly after federal
transportation minister Wolfgang Tiefensee
intervened. A strike in November affected
many chemical manufacturers in Germany and
Central Europe.
Truck drivers in the UK are also expected to
go on strike at some point. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
New
Logistics Regs Expected for China
In
the wake of a court case about damage
resulting from hazardous chemicals in a
plane, the Chinese government is expected to
introduce stricter transportation
regulations. China National Chemical
Constriction Corp. lied about cargo that
leaked on an Airbus A330 in 2000, causing
extensive damage. The Beijing Higher
People's Court ordered the state-owned
company to pay $65 million (Euro 44.2
million) in damages. As a result of the
case, the China Logistics Association is
anticipating tighter standards for packaging
and third-party transporters. New
regulations could address loopholes that
allow for the submission of fake samples and
make it more difficult for companies to
become approved transporters. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Port
Security an Issue for Chemical Shippers
Chemical companies face two major types of
risks when shipping chemicals. One is the
shipment of inherently toxic/hazardous
materials. The other is the shipment of
nonhazardous materials that could be used
for the purposes of terrorism in some way.
To avoid problems with hazardous materials,
companies are looking to substitute such
products with nonhazardous replacements. If
that is not an option, alternative sourcing
arrangements through exchanges, swaps,
contract manufacturing and purchases are
being developed. Using these methods, Dow
Chemical has reduced its highly hazardous
material tonne per mile by 29 percent.
Actions of chemical companies, of course,
cannot prevent missile detonations or
large-scale terrorist attacks. That effort
must originate with governments. Ports are
critical to trade around the world and are
expanding continuously to meet the growing
needs of the sector. Unfortunately, this
means that security is an issue. Only about
2 to 5 percent of the international cargo
entering the United States is scanned. The
government is wrestling with how to address
the issue without bringing the movement of
goods to a standstill. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Reach
Guidance Causing Confusion
In
Europe, companies have less than six months
to preregister their products that are
marketed in the EU in volumes of more than
one tonne per year, according to the Reach
implementation legislation requirements.
Seven Reach Implementation projects (RIPs)
have been designed to define how the program
will work, and to provide guidance and
support tools. Many companies are finding
the guidance material as complex and
confusing as the legislation itself. The
RIPs \are not legally binding, but deviation
from them will draw attention.
RIP 1 is an introductory package of
information and is available only
electronically. RIP 2 focuses on IT systems
and connecting through the Web to the
European Chemicals Agency for online
preregistration, notification and reporting.
RIP 3, the most important and unclear of the
first three guidance materials, discusses
registration and substance identification,
and it leaves room for different
interpretations among different EU
countries. Data sharing is also required,
but companies must do so without colluding.
How that is to be achieved is not
understood. Clarifications are coming too
slowly for most manufacturers, who find the
technical guidance document far too
complicated to be meaningful.
RIP 4 contains guidance for regulatory
authorities, RIPs 5 and 6 create the
European Chemical Agency and RIP 7 covers
those preparations that the European
Commission must make.
The cost of registration for is estimated by
companies to be anywhere between $60,000 to
$120,000 per chemical. The concept of one
substance, one registration (OSOR) allows
the formation of consortia to jointly
register substances, but there are many
legal issues concerning what activities will
be permitted by such groups given current
antitrust regulations. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
| |
|
|
 |
 |
 |
Famous
Quotes of the Month
"I've learned that failure preceded success,
and the right decisions are an extension of
the wrong ones." (Alex Spanos)
"One of the tests of leadership is the
ability to recognize a problem before it
becomes an emergency." (Arnold H. Glasow)
"We are all travelers in the wilderness of
this world, and the best we can find in our
travels is an honest friend." (Robert Louis
Stevenson) |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|
 |
 |
 |
Before You
Make a Beeline for the Door....
Question: Is it true that the laws of
physics make it impossible for bumblebees to
fly? They seem to be able to, in defiance of
physics. Why?
Answer: It is true that a basic equation
from aeronautics makes the flight of the
bumblebee impossible. The equation relates
the thrust required for an object to fly to
its mass and the surface area of its wings.
In the case of bees, this means the small
animal would have to do an impossible amount
of work to get airborne.
So how does the tireless bumblebee pull off
the flying feat?
Well, the equation is flawed. It assumes
that a stationary object rather than one
with flapping wings is trying to fly. The
bumblebee is not one to depend on a passing
breeze to take flight, right? The power is
in the flapping, and a little wind can only
help. |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
| |
|
|